Literature DB >> 29138174

First Nations hepatitis C virus infections: Six-year retrospective study of on-reserve rates of newly reported infections in northwestern Ontario.

Janet Gordon1, Natalie Bocking2, Kathy Pouteau3, Terri Farrell4, Gareth Ryan5, Len Kelly6.   

Abstract

OBJECTIVE: To document rates of newly reported hepatitis C virus (HCV) cases from 2010 to 2015 in remote First Nations communities.
DESIGN: Retrospective analysis of aggregate data of newly reported HCV antibody-positive (Ab+) cases.
SETTING: Northwestern Ontario. PARTICIPANTS: A total of 31 First Nations communities (an on-reserve population of 20 901) supported in health care by the Sioux Lookout First Nations Health Authority. MAIN OUTCOME MEASURES: The aggregate characteristic data included year of notification, age range, and sex for a 6-year period (2010 to 2015).
RESULTS: There were 267 HCV Ab+ cases in the 6-year study period. The incidence in 2015 was 324.2 per 100 000 population. This is 11 times the rate for all of Ontario. The most common associated risk factor was sharing of intravenous drug use equipment. Women made up 52% of patients with newly reported HCV Ab+ cases. More than 45% of cases were in patients between 20 and 29 years of age.
CONCLUSION: This high burden of newly reported HCV Ab+ cases in geographically remote First Nations communities is concerning, and prevention and treatment resources are needed. This burden of disease might pose more urgent health and social challenges than can be generalized from the experience of the rest of Canada. Copyright© the College of Family Physicians of Canada.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29138174      PMCID: PMC5685465     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  22 in total

1.  Enhanced surveillance of newly acquired hepatitis C virus infection in Canada, 1998 to 2004.

Authors:  Hong-Xing Wu; Jun Wu; Tom Wong; Tracey Donaldson; Katherine Dinner; Anton Andonov; Jessica Ip Chan; Barbara Moffat; Beverley Baptiste; Janet Furseth; Darlene Poliquin; Grlica Bolesnikov; Antonio Giulivi; Shirley Paton
Journal:  Scand J Infect Dis       Date:  2006

2.  Incidence of narcotic abuse during pregnancy in northwestern Ontario: three-year prospective cohort study.

Authors:  Len Kelly; John Guilfoyle; Joe Dooley; Irwin Antone; Lianne Gerber-Finn; Roisin Dooley; Nicole Brunton; Kara Kakegamuck; Jill Muileboom; Wilma Hopman; Helen Cromarty; Barb Linkewich; Jennifer Maki
Journal:  Can Fam Physician       Date:  2014-10       Impact factor: 3.275

3.  Community-wide measures of wellness in a remote First Nations community experiencing opioid dependence: evaluating outpatient buprenorphine-naloxone substitution therapy in the context of a First Nations healing program.

Authors:  Dinah Kanate; David Folk; Sharon Cirone; Janet Gordon; Mike Kirlew; Terri Veale; Natalie Bocking; Sara Rea; Len Kelly
Journal:  Can Fam Physician       Date:  2015-02       Impact factor: 3.275

4.  The Need to Expand Access to Hepatitis C Virus Drugs in the Indian Health Service.

Authors:  Jessica Leston; Joe Finkbonner
Journal:  JAMA       Date:  2016 Aug 23-30       Impact factor: 56.272

5.  Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.

Authors:  D M Patrick; M W Tyndall; P G Cornelisse; K Li; C H Sherlock; M L Rekart; S A Strathdee; S L Currie; M T Schechter; M V O'Shaughnessy
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

6.  A gendered analysis of Canadian Aboriginal individuals admitted to inpatient substance abuse detoxification: a three-year medical chart review.

Authors:  Russell C Callaghan; Randi Cull; Lisa C Vettese; Lawren Taylor
Journal:  Am J Addict       Date:  2006 Sep-Oct

7.  Evaluation of 6 remote First Nations community-based buprenorphine programs in northwestern Ontario: Retrospective study.

Authors:  Solomon Mamakwa; Meldon Kahan; Dinah Kanate; Mike Kirlew; David Folk; Sharon Cirone; Sara Rea; Pierre Parsons; Craig Edwards; Janet Gordon; Fiona Main; Len Kelly
Journal:  Can Fam Physician       Date:  2017-02       Impact factor: 3.275

8.  Demographic, risk behaviour and personal network variables associated with prevalent hepatitis C, hepatitis B, and HIV infection in injection drug users in Winnipeg, Canada.

Authors:  John L Wylie; Lena Shah; Ann M Jolly
Journal:  BMC Public Health       Date:  2006-09-13       Impact factor: 3.295

9.  Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population.

Authors:  Naana Afua Jumah; Craig Edwards; Jazmyn Balfour-Boehm; Kassandra Loewen; Joseph Dooley; Lianne Gerber Finn; Len Kelly
Journal:  BMJ Open       Date:  2016-10-31       Impact factor: 2.692

Review 10.  Hepatitis C virus in American Indian/Alaskan Native and Aboriginal peoples of North America.

Authors:  Julia D Rempel; Julia Uhanova
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

View more
  8 in total

1.  Correction.

Authors: 
Journal:  Can Fam Physician       Date:  2018-01       Impact factor: 3.275

Review 2.  Hepatitis C models of care: approaches to elimination.

Authors:  Mia J Biondi; Jordan J Feld
Journal:  Can Liver J       Date:  2020-06-04

Review 3.  Contextualizing Canada's hepatitis C virus epidemic.

Authors:  Mel Krajden; Darrel Cook; Naveed Z Janjua
Journal:  Can Liver J       Date:  2018-12-25

4.  Annual Meeting of the Canadian Association for the Study of the Liver (CASL), the Canadian Network on Hepatitis C (CANHEPC) and the Canadian Association of Hepatology Nurses (CAHN) 2021 Abstracts.

Authors: 
Journal:  Can Liver J       Date:  2021-04-29

5.  A collaborative approach to hepatitis C testing in two First Nations communities of northwest Ontario.

Authors:  David Smookler; Anne Beck; Brenda Head; Leroy Quoquat; Cheyanne Albany; Terri Farrell; Janet Gordon; Nancy Thurston; Lucy You; Camelia Capraru; Mike McKay; John Kim; Jordan J Feld; Hemant Shah
Journal:  Can Liver J       Date:  2022-08-16

6.  The hepatitis C epidemic in Canada: An overview of recent trends in surveillance, injection drug use, harm reduction and treatment.

Authors:  Lillian Lourenço; Marian Kelly; Jill Tarasuk; Kyla Stairs; Maggie Bryson; Nashira Popovic; Josephine Aho
Journal:  Can Commun Dis Rep       Date:  2021-12-09

7.  Interventions to Improve Uptake of Direct-Acting Antivirals for Hepatitis C Virus in Priority Populations: A Systematic Review.

Authors:  David Ortiz-Paredes; Afia Amoako; Taline Ekmekjian; Kim Engler; Bertrand Lebouché; Marina B Klein
Journal:  Front Public Health       Date:  2022-06-24

8.  "I want to get better, but…": identifying the perceptions and experiences of people who inject drugs with respect to evolving hepatitis C virus treatments.

Authors:  Trevor Goodyear; Helen Brown; Annette J Browne; Peter Hoong; Lianping Ti; Rod Knight
Journal:  Int J Equity Health       Date:  2021-03-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.